The concentrations of hormones measured in serum from maternal blood change dramatically dunng pregnancy. While the relative contributions of sex steroids shift from maternal ovaries and adrenals to the fetoplacental unit, other maternal tissues such as pituitaryand liver respond to increasing concentrations of estrogen and secrete increasing amounts of prolactin and sex-hormone-binding globulin. To determine longitudinalchanges in circulating maternal hormones, we collected blood from 60 women on three occasions during their pregnancies. We observed a 1.7-fold increase in testosterone concentrationin serum; concentrations of sex-hormone-binding globulin in serum rose 5.6-fold. The major increase (6.8-fold) in estradiol in serum occurred within the first 16 weeks, followed by a further 4.8-fold increase by term. Mean concentrations of progesterone, 17-hydroxyprogesterone, and androstenedione in serum increased 11.9-, 3-, and 1.3-fold, respectively, whereas concentrations of dehydroepiandrosterone sulfate (DHEAS) fell by 50%. Mean serum prolactin concentrations increased 3.8-fold during the first trimester and by a similar amount during the final 24 weeks of pregnancy. We used these data, obtained from a cohort of women with uncomplicated pregnancies, to construct reference intervals for hormones in maternal serum. study was to measure hormones in serum in a group of women during normal pregnancy and to determine reference ranges for these analytes. The assays reported in this study were performed with commercial kits that are available in most routine laboratories.
During pregnancy, substantial changes occur in the circulating concentrations of binding proteins and hormones in maternal serum. In addition, changes in the secretion and metabolism of steroids by the fetoplacental unit produce a dynamic pool of hormones within maternal serum. Measurements of several maternal hormones in serum, particularly human choriogonadotropin (1) and, to a lesser extent, placental lactogen (2) and estriol (3) have proven useful clinically in assessing at-risk pregnancy. Because many previous reports were based on cross-sectional investigations or involved various specialized nonroutine methods, it is difficult to compare results for different hormones. The aim of this ' study was to measure hormones in serum in a group of women during normal pregnancy and to determine reference ranges for these analytes. The assays reported in this study were performed with commercial kits that are available in most routine laboratories.
Materials and Methods

Patients
Three blood samples were collected from 108 pregnant women during each trimester of pregnancy-at weeks 6 with log-transformed data, to homogenize variance. We then plotted the exponents of these data to give ranges on the original scale. We noted an apparent surplus of points outside the limits in some cases because of correlations between measurements on the same individual. Plots of the data for log(testosterone) and log(androstenedione) indicated outliers that would have undue influence on the fitting procedure. These outliers were omitted from the final statistical analysis and are therefore not identified on the plots.
Results
Sixty infants were born to the women in this study, 27 nmol/L at week 5 to 11.13 (4.69-26.40) nmol/L at week 16. During the second and third trimesters, the mean estradiol concentration in serum rose almost fivefold, to 53.44 (22.53-127) nmol/L at week 40 (Figure 4 ).
Prolactin.
Prolactin results are expressed as milliinternational During the first nine weeks of pregnancy, the corpus luteum and, to a lesser extent, the maternal ovary and adrenal cortex contribute to circulating concentrations of maternal steroids (5, 6). After that time, the placenta becomes the predominant source of maternal steroids (7) . Increased production of estradiol, in particular, affects hepatic synthesis of binding proteins such as thyroxin-binding globulin and SHBG as well as pituitary gland secretion of prolactin (8) (9) (10) . We undertook this longitudinal study of the latter 35 weeks of gestation to define appropriate hormone ranges for several analytes known to alter markedly during pregnancy.
Progesteroneand 17-Hydroxyprogesterone
Whereas estrogen production during pregnancy derives from precursors formed within the fetal and maternal compartments, placental progesterone production is derived mainly from the maternal pool of circulating cholesterol (11, 12 one (17) . Our longitudinal study confirms that the increase in 17-hydroxyprogesterone concentrations in maternal serum occurs predominantly during the second half of pregnancy, as was previously reported in cross-sectional (5) and longitudinal studies (15).
17-Hydroxyprogesterone is generally accepted to in-
SHBG and Testosterone
The concentration of SHBG in serum Previous reports have suggested that the abnormal conceptusdoesnot produce sufficient estrogen to stimulate SHBG production and increase testosterone concentrations (18, 19) .
Ordinarily, 98% of the total circulating testosterone is bound to serum binding proteins (SHBG and albumin), whereas 2% is free (18, 24) . It is generally believed that SHBG-bound testosterone is not biologically active. The relative bioavailability of free and albumin-bound test.: osterone is debated (25, 26) , whereas the non-SHBGbound testosterone is considered to be the biologically active moiety (27) . The FM is commonly used as an index of biologically active testosterone in men and nonpregnant women (28,29) . Assuming that the affinity of SHBG for testosterone does not change during pregnancy (we are not aware of any such evidence), the FM would reasonably reflect the non-SHBG-bound fraction of total testosterone.
A two-to threefold increase in SHBG-binding capacity during pregnancy, mainly in the first trimester, has been reported previously (9). In our longitudinal study, we observed a 5. to produce the estrogens (23). We observed a 50% reduction in maternal DHEAS concentrations during the first half of pregnancy, similar to that observed previously (32); this reflects, in part, a six-to 10-fold increase in the clearance rate of DHEAS (33). We observed only a slight increase in androstenedione concentrations in our longitudinal study of normal pregnancy, consistent with previous reports (34, 35) .
Estradiol
After the first five to six weeks of pregnancy, the major sourceof estradiol is the placenta, where enzymes convert maternal and fetal DHEAS to estradiol, estrone, and estriol (5). Near term, 50% of the estradiol synthesized in the placenta is derived from precursors in the fetal circulation; the remainder comes from precursors in the maternal circulation (36). The estradiol concentrations we report are similar to those reported by others (34, 37, 38) . A direct assay of estradiol may be affected by high SHBG concentrations during the latter half of pregnancy in a manner similar to that described previously for testosterone (20) and estradiol (39) We observed a rapid increase in estradiol concentrations, particularly between weeks 20 and 35, which is most likely due to the enhanced aromatization of circulating DHEAS by the increasing mass of placental tissue (23,31,37) . Low concentrations of estradiol measured in maternal serum during the first trimester are suggested to be an indicator of poor prognosis in cases of threatened abortion (1). However, because of the large overlap between low and normal values during the third trimester, estradiol measurements donot appear to offer useful information to predict clinical outcome (40) (41) (42) .
Prolactin
Our longitudinal data for prolactin in maternal serum are consistent with earlier studies that showed that prolactin concentrations increase significantly during pregnancy (10, 43) because of estrogen-induced hyperplasia and hypertrophy of pituitary lactotrophs (44) . We observed an increase in the mean prolactin concentrations in maternal serum that strongly correlates with the mean circulating estradiol concentrations (r = 0.9997, P <0.05; Spearman rank correlation coefficient).
Despite the many technical advances in measuring hormone concentrations in serum, there is no clear consensus as to why production of these hormones is increased during pregnancy or what their function is. Why does the system require seemingly excessive amounts of circulating steroids and protein hormones in the mother? If, as it would appear reasonable to assume, gestation represents a coordinated process,there must be an integrated control of information across the placenta from fetus to mother. Further analysis of hormone fluxes may lead to a greater understanding of the hormonal control of fetal and placental growth.
Many previous studies have reported changes in hormone concentrations in serum during pregnancy, but few have attempted to define "normal" limits based on prospective studies. There is clearly a need to examine those changes that occur during normal pregnancy so that unusual or unexpected trends can be identified. Furthermore, becausehormone measurements in serum are most likely to be performed in laboratories that use commercially available reagents, at least for the first measurement, we used such methods to obtain the data presented here to detail hormone changes in serum during normal pregnancy. Australia for the Diagnostic Products Corporation radioimmunoassay kits used in this study.
